Prognosis of patients with unstable angina or acute myocardial infarction treated with calcium channel antagonists.
The safety of calcium channel antagonists has become a controversial issue among cardiologists. Thus, the role of calcium antagonists in the treatment of myocardial infarction is reviewed, and the differences among the 3 classes of calcium channel antagonists, phenylalkylamines, dihydropyridines, and benzothiazepines, are discussed.